| Autor: |
Stenver, D., Nielsen, B. |
| Zdroj: |
International Journal of Artificial Organs; August 1990, Vol. 13 Issue: 8 p474-476, 3p |
| Abstrakt: |
We evaluated the need for erythropoietin (EPO) treatment in 134 end-stage renal disease patients assuming a level of hemoglobin below 6 mmol/l (9.6 g/dl) as indication for treatment. 91 patients (68%) fulfilled this criterion. Absolute contraindications in 2 patients were previous thrombotic encephalopathy and refusal of treatment. Relative contraindications due to cardiac disease were found in 3 patients. In 15 patients additional treatment was required because of hypertension (5) or deficiency states (10). The implications of elevated serum PTH and aluminum overload are discussed. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
